Partner Content Partner Content Beyond Immunotherapies Latest innovations emerging from immunotherapy research
Partner Content Partner Content Managing Multi-Arm Studies in an Evolving Immuno-Oncology La... Collaborate with CROs and sites to help minimize risks
Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
Views & Analysis The top three benefits to commercial outsourcing in pharma In the face of continuing industrial and technological progress – and the resulting imperative for business agility – commercial outsourcing has come of age not a moment too soon.
White Papers Sponsored Seizing the potential of commercial outsourcing in the pharm... The power and potential of outsourcing has long been recognised as a core enabler of business growth.
Views & Analysis Getting it right: the UK’s pathway for 2017 The implications for global pharma HQs and what the UK needs to do.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
